AIM
Aigen Investment Management’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-15,621
| Closed | -$342K | – | 778 |
|
|
2025
Q1 | $342K | Buy |
+15,621
| New | +$342K | 0.05% | 459 |
|
|
2024
Q2 | – | Sell |
-5,560
| Closed | -$327K | – | 761 |
|
|
2024
Q1 | $327K | Buy |
+5,560
| New | +$327K | 0.07% | 404 |
|
|
2023
Q3 | – | Sell |
-21,827
| Closed | -$1.99M | – | 813 |
|
|
2023
Q2 | $1.99M | Buy |
+21,827
| New | +$1.99M | 0.29% | 90 |
|
|
2022
Q4 | – | Sell |
-3,438
| Closed | -$235K | – | 524 |
|
|
2022
Q3 | $235K | Buy |
+3,438
| New | +$235K | 0.03% | 474 |
|
|
2021
Q3 | – | Sell |
-5,097
| Closed | -$322K | – | 464 |
|
|
2021
Q2 | $322K | Buy |
+5,097
| New | +$322K | 0.06% | 318 |
|
|
2020
Q4 | – | Sell |
-10,308
| Closed | -$311K | – | 775 |
|
|
2020
Q3 | $311K | Buy |
+10,308
| New | +$311K | 0.04% | 528 |
|
|
2020
Q2 | – | Sell |
-29,412
| Closed | -$788K | – | 810 |
|
|
2020
Q1 | $788K | Buy |
+29,412
| New | +$788K | 0.1% | 281 |
|